Emily Blodget

Emily Blodget, MD serves as an Associate Professor in the Division of Infectious Diseases within the Department of Medicine at the University of California, Irvine School of Medicine. Her clinical and research focus centers on infectious disease management in solid organ transplant recipients.

Her primary research interests include transplant infectious disease, with particular expertise in COVID-19 treatment protocols for immunocompromised patients. Dr. Blodget has conducted significant research on monoclonal antibody therapies for transplant patients, examining their impact on hospitalization rates and mortality outcomes during the pandemic.

Her notable publication analyzed the effectiveness of outpatient monoclonal antibody therapy in abdominal organ transplant recipients with COVID-19, demonstrating significant reductions in hospitalization and mortality rates. This work represents an important contribution to the field of transplant infectious disease management during public health emergencies.

Dr. Blodget's research has contributed to developing clinical protocols for early outpatient intervention in transplant patients with infectious diseases, particularly during the peak of the Los Angeles COVID-19 outbreak in December 2020. Her work emphasizes the importance of aggressive approaches to managing infectious diseases in this vulnerable patient population.